Focus: Resolve Therapeutics is a public-stage biotechnology company headquartered in Miami focused on biologics development across cardiovascular, immunology, and infectious disease therapeutics. The company maintains a lean operational footprint with minimal public disclosure on employee count and financials.
Profile data last refreshed 5h ago · AI intelligence enriched 4d ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Resolve is a high-risk, high-upside play best suited for early-career scientists willing to bet on a single lead program and tight-knit team culture in a pre-commercial biotech.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Resolve Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Resolve Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo